Mozambique Drug Abuse Report 2026: 17,783 Treated for Drug-Related Disorders

• During the first half of 2026, 17,783 individuals received treatment in Mozambican health facilities for mental and behavioural disorders.
• These disorders were directly linked to the use of drugs and other psychoactive substances.
• The data was published in the National Report on Drug Trafficking and Consumption by the Central Office for the Prevention and Control of Drugs (GCPCD).
• The report highlights a significant public health challenge stemming from substance abuse in Mozambique.
• The findings are crucial for informing public health policies and legal strategies to address drug-related issues.

The sheer volume of cases underscores the pervasive impact of substance abuse on the nation's healthcare system and its population.

A significant public health challenge in Mozambique has been highlighted by recent data, indicating that during the first six months of 2026, a total of 17,783 individuals sought medical attention at various Mozambican health facilities. These treatments were specifically for mental and behavioural disorders that arose directly from the consumption of drugs and other psychoactive substances. The sheer volume of cases underscores the pervasive impact of substance abuse on the nation's healthcare system and its population.

This critical information originates from the National Report on Drug Trafficking and Consumption, a comprehensive document that sheds light on the scale of drug-related issues within the country. The report, compiled and released by the Central Office for the Prevention and Control of Drugs (GCPCD), serves as a vital resource for understanding the current landscape of substance abuse and its associated health consequences. The Mozambique drug abuse report 2026 provides a stark snapshot of the immediate health burdens faced by communities across the nation.

The data presented in the GCPCD Mozambique drug consumption report points to a pressing need for targeted interventions and robust public health strategies. The focus on mental and behavioural disorders as the primary reason for treatment indicates that the impact of drug use extends beyond immediate physical harm, deeply affecting cognitive functions and psychological well-being. This category of disorders often requires specialized and long-term care, placing considerable strain on existing health infrastructure.

The National Report Drug Trafficking Mozambique not only quantifies the number of individuals treated but also implicitly calls attention to the types of psychoactive substances prevalent in the country. While specific substances are not detailed in this particular finding, the broad categorization suggests a diverse array of drugs contributing to the problem. These Mozambique psychoactive substance abuse statistics are crucial for policymakers and healthcare providers to tailor prevention, treatment, and rehabilitation programs effectively.

The findings from the first half of 2026 are instrumental for informing public health policy and legal frameworks in Mozambique. The high number of drug-related mental disorders Mozambique residents are experiencing necessitates a multi-faceted approach, encompassing not only treatment but also prevention, education, and law enforcement efforts to curb drug trafficking. This Mozambique public health drug data provides a factual basis for allocating resources and developing evidence-based strategies to combat the escalating problem of substance abuse.

For legal and compliance professionals, the insights from this report are invaluable for risk assessments and corporate social responsibility initiatives. Understanding the prevalence of drug-related mental disorders Mozambique faces can guide decisions related to workplace safety, community engagement, and advocacy for stronger public health measures. The ongoing monitoring and reporting by entities like the GCPCD are essential for tracking progress and adapting strategies to the dynamic nature of drug consumption and its societal impacts.

This report provides crucial data on drug consumption and its health impacts in Mozambique, which lawyers and compliance officers can use to inform risk assessments, policy advocacy, or corporate social responsibility strategies related to public health and substance abuse.

Source: Original reporting via AIM